
COMMISSION REGULATION (EU) No 605/2014 of 5 June 2014 amending, for the purposes of introducing hazard and precautionary statements in the Croatian language and its adaptation to technical and scientific progress, Regulation (EC) No 1272/2008 of the European Parliament and of the Council on classification, labelling and packaging of substances and mixtures (Text with EEA relevance) 

THE EUROPEAN COMMISSION,
Having regard to the Treaty on the Functioning of the European Union,
Having regard to the Act concerning the conditions of accession of the Republic of Croatia and the adjustments to the Treaty on European Union and the Treaty establishing the European Atomic Energy Community, and in particular Article 50 thereof,
Having regard to Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC, and amending Regulation (EC) No 1907/2006, and in particular Article 37(5) thereof,
Whereas:

(1) Commission Regulation (EU) No 487/2013 amends some of the language tables for hazard statements included in Annex III to Regulation (EC) No 1272/2008 and some of the language tables for precautionary statements included in Annex IV to that Regulation. With the accession of Croatia to the European Union on 1 July 2013, it is necessary that all hazard and precautionary statements provided for by Regulation (EC) No 1272/2008 as amended by Commission Regulation (EU) No 487/2013 are available in the Croatian language as well. This Regulation introduces the necessary adjustments to the language tables.

(2) Part 3 of Annex VI to Regulation (EC) No 1272/2008 contains two lists of harmonised classification and labelling of hazardous substances. Table 3.1 lists the harmonised classification and labelling of hazardous substances based on the criteria set out in Parts 2 to 5 of Annex I to Regulation (EC) No 1272/2008. Table 3.2 lists the harmonised classification and labelling of hazardous substances based on the criteria set out in Annex VI to Council Directive 67/548/EEC.

(3) Proposals for new or updated harmonised classification and labelling of certain substances have been submitted to the European Chemicals Agency (ECHA) pursuant to Article 37 of Regulation (EC) No 1272/2008. Based on the opinions on those proposals issued by the Committee for Risk Assessment of ECHA, as well as on the comments received from the parties concerned, it is appropriate to introduce, remove or update harmonised classification and labelling of certain substances by amending Annex VI to that Regulation.

(4) Compliance with the new harmonised classifications should not be required immediately, as a certain period of time will be necessary to allow suppliers to adapt the labelling and packaging of substances and mixtures to the new classifications and to sell existing stocks. In addition, a certain period of time will be necessary to allow suppliers to comply with the registration obligations resulting from the new harmonised classifications for substances classified as carcinogenic, mutagenic or toxic to reproduction, categories 1A and 1B (Table 3.1) and categories 1 and 2 (Table 3.2), or as very toxic to aquatic organisms which may cause long term effects in the aquatic environment, in particular with those set out in Article 23 of Regulation (EC) No 1907/2006 of the European Parliament and of the Council.

(5) In line with the transitional provisions of Regulation (EC) No 1272/2008 which allow the application of the new provisions at an earlier stage on a voluntary basis, suppliers should have the possibility of applying the new harmonised classifications and of adapting the labelling and packaging accordingly on a voluntary basis before the deadline for compliance.

(6) The measures provided for in this Regulation are in accordance with the opinion of the Committee established under Article 133 of Regulation (EC) No 1907/2006,
HAS ADOPTED THIS REGULATION:

Article 1 
Regulation (EC) No 1272/2008 is amended as follows:

((1)) Annex III is amended in accordance with Annex I to this Regulation;
((2)) Annex IV is amended in accordance with Annex II to this Regulation;
((3)) Annex VI is amended in accordance with Annex III to this Regulation.
Article 2 

1. By way of derogation from Article 3(2), substances and mixtures may, before 1 December 2014 and 1 June 2015 respectively, be classified, labelled and packaged in accordance with this Regulation.
2. By way of derogation from Article 3(2), substances classified, labelled and packaged in accordance with Regulation (EC) No 1272/2008 and placed on the market before 1 December 2014, shall not be required to be relabelled and repackaged in accordance with this Regulation until 1 December 2016.
3. By way of derogation from Article 3(2), mixtures classified, labelled and packaged in accordance with Directive 1999/45/EC of the European Parliament and of the Council or Regulation (EC) No 1272/2008 and placed on the market before 1 June 2015, shall not be required to be relabelled and repackaged in accordance with this Regulation until 1 June 2017.
4. By way of derogation from Article 3(3), the harmonised classifications set out in Annex III to this Regulation may be applied before the date referred to in Article 3(3).
Article 3 

1. This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.
2. Article 1(1) and (2) shall apply in respect of substances from 1 December 2014 and in respect of mixtures from 1 June 2015.
3. Article 1(3) shall apply from 1 January 2016.
This Regulation shall be binding in its entirety and directly applicable in all Member States.
ANNEX I

In Part 1 of Annex III, Table 1.1 is amended as follows:

((1)) in code H229, the following is inserted after the entry corresponding to GA:
'
 HR Spremnik pod tlakom: može se rasprsnuti ako se grije.'
((2)) in code H230, the following is inserted after the entry corresponding to GA:
'
 HR Može eksplozivno reagirati i bez prisustva zraka.'
((3)) in code H231, the following is inserted after the entry corresponding to GA:
'
 HR Može eksplozivno reagirati i bez prisustva zraka na povišenom tlaku i/ili temperaturi.'

ANNEX II

Part 2 to Annex IV is amended as follows:

((1)) Table 1.2 is amended as follows:

((a)) in code P210, the following is inserted after the entry corresponding to GA:
'
 HR Čuvati odvojeno od topline, vrućih površina, iskri, otvorenih plamena i ostalih izvora paljenja. Ne pušiti.'
((b)) in code P223: The following is inserted after the entry corresponding to GA:
'
 HR Spriječiti dodir s vodom.'
((c)) in code P244, the following is inserted after the entry corresponding to GA:
'
 HR Spriječiti dodir ventila i spojnica s uljem i masti.'
((d)) in code P251, the following is inserted after the entry corresponding to GA:
'
 HR Ne bušiti, niti paliti čak niti nakon uporabe.'
((e)) in code P284, the following is inserted after the entry corresponding to GA:
'
 HR [U slučaju nedovoljne ventilacije] nositi sredstva za zaštitu dišnog sustava.'
((2)) Table 1.3 is amended as follows:

((a)) in code P310, the following is inserted after the entry corresponding to GA:
'
 HR Odmah nazvati CENTAR ZA KONTROLU OTROVANJA/liječnika/…'
((b)) in code P 311, the following is inserted after the entry corresponding to GA:
'
 HR Nazvati CENTAR ZA KONTROLU OTROVANJA/liječnika/…'
((c)) in code P312: The following is inserted after the entry corresponding to GA:
'
 HR U slučaju zdravstvenih tegoba nazvati CENTAR ZA KONTROLU OTROVANJA/liječnika/…'
((d)) in code P340, the following is inserted after the entry corresponding to GA:
'
 HR Premjestiti osobu na svježi zrak i postaviti ju u položaj koji olakšava disanje.'
((e)) in code P352, the following is inserted after the entry corresponding to GA:
'
 HR Oprati velikom količinom vode/…'
((f)) in code P361, the following is inserted after the entry corresponding to GA:
'
 HR Odmah skinuti svu zagađenu odjeću.'
((g)) in code P362, the following is inserted after the entry corresponding to GA:
'
 HR Skinuti zagađenu odjeću.'
((h)) in code P364, the following is inserted after the entry corresponding to GA:
'
 HR I oprati je prije ponovne uporabe.'
((i)) in code P378, the following is inserted after the entry GA:
'
 HR Za gašenje rabiti …'
((j)) in combined codes P301 + P310, the following is inserted after the entry corresponding to GA:
'
 HR AKO SE PROGUTA: odmah nazvati CENTAR ZA KONTROLU OTROVANJA/liječnika/…'
((k)) in combined codes P301 + P312, the following is inserted after the entry corresponding to GA:
'
 HR AKO SE PROGUTA: u slučaju zdravstvenih tegoba nazvati CENTAR ZA KONTROLU OTROVANJA/liječnika/…'
((l)) in combined codes P302 + P352, the following is inserted after the entry corresponding to GA:
'
 HR U SLUČAJU DODIRA S KOŽOM: oprati velikom količinom vode/…'
((m)) in combined codes P303 + P361+P353, the following is inserted after the entry corresponding to GA:
'
 HR U SLUČAJU DODIRA S KOŽOM (ili kosom): odmah skinuti svu zagađenu odjeću. Isprati kožu vodom/tuširanjem.'
((n)) in combined codes P304 + P340, the following is inserted after the entry corresponding to GA:
'
 HR AKO SE UDIŠE: premjestiti osobu na svježi zrak i postaviti ju u položaj koji olakšava disanje.'
((o)) in combined codes P308 + P311, the following is inserted after the entry corresponding to GA:
'
 HR U SLUČAJU izloženosti ili sumnje na izloženost: nazvati CENTAR ZA KONTROLU OTROVANJA/liječnika/…'
((p)) in combined codes P342 + P311, the following is inserted after the entry corresponding to GA:
'
 HR Pri otežanom disanju: nazvati CENTAR ZA KONTROLU OTROVANJA/liječnika/…'
((q)) in combined codes P361 + P364, the following is inserted after the entry corresponding to GA:
'
 HR Odmah skinuti svu zagađenu odjeću i oprati je prije ponovne uporabe.'
((r)) in combined codes P362 + P364, the following is inserted after the entry corresponding to GA:
'
 HR Skinuti zagađenu odjeću i oprati je prije ponovne uporabe.'
((s)) in combined codes P370 + P378, the following is inserted after the entry corresponding to GA:
'
 HR U slučaju požara: za gašenje rabiti …'

ANNEX III

Part 3 of Annex VI is amended as follows:

((1)) Table 3.1 is amended as follows:

((a)) the entry corresponding to index number 015-188-00-X is deleted;
((b)) the entries corresponding to index numbers 006-086-00-6, 015-154-00-4, 015-192-00-1, 601-023-00-4, 601-026-00-0, 603-061-00-7, 605-001-00-5, 605-008-00-3 and 616-035-00-5 are replaced by the following corresponding entries:
'
006-086-00-6 fenoxycarb (ISO); ethyl [2-(4-phenoxyphenoxy)ethyl]carbamate 276-696-7 72490-01-8 Carc. 2Aquatic Acute 1Aquatic Chronic 1 H351H400H410 GHS08GHS09Wng H351H410  M = 1M = 10 000 
015-154-00-4 ethephon; 2-chloroethylphosphonic acid 240-718-3 16672-87-0 Acute Tox. 3Acute Tox. 4Acute Tox. 4Skin Corr. 1CAquatic Chronic 2 H311H332H302H314H411 GHS06GHS05GHS09Dgr H311H332H302H314H411 EUH071  
015-192-00-1 tetrakis(2,6-dimethylphenyl)-m-phenylene biphosphate 432-770-2 139189-30-3 Skin Sens. 1 H317 GHS07Wng H317   
601-023-00-4 ethylbenzene 202-849-4 100-41-4 Flam. Liq. 2Acute Tox. 4*STOT RE 2Asp. Tox. 1 H225H332H373 (hearing organs)H304 GHS02GHS07GHS08Dgr H225H332H373 (hearing organs)H304   
601-026-00-0 styrene 202-851-5 100-42-5 Flam. Liq. 3Repr. 2Acute Tox. 4*STOT RE 1Skin Irrit. 2Eye Irrit. 2 H226H361dH332H372 (hearing organs)H315H319 GHS02GHS08GHS07Dgr H226H361dH332H372 (hearing organs)H315H319  * D
603-061-00-7 tetrahydro-2-furylmethanol;tetrahydrofurfuryl alcohol 202-625-6 97-99-4 Repr. 1BEye Irrit. 2 H360DfH319 GHS08GHS07Dgr H360DfH319   
605-001-00-5 formaldehyde …% 200-001-8 50-00-0 Carc. 1BMuta. 2Acute Tox. 3*Acute Tox. 3*Acute Tox. 3*Skin Corr. 1BSkin Sens. 1 H350H341H301H311H331H314H317 GHS08GHS06GHS05Dgr H350H341H301H311H331H314H317  *Skin Corr. 1B; H314: C ≥ 25 %Skin Irrit. 2; H315: 5 % ≤ C < 25 %Eye Irrit. 2; H319: 5 % ≤ C < 25 %STOT SE 3; H335: C ≥ 5 %Skin Sens. 1; H317: C ≥ 0,2 % B, D
605-008-00-3 acrolein;prop-2-enal;acrylaldehyde 203-453-4 107-02-8 Flam. Liq. 2Acute Tox. 1Acute Tox. 2Acute Tox. 3Skin Corr. 1BAquatic Acute 1Aquatic Chronic 1 H225H330H300H311H314H400H410 GHS02GHS06GHS05GHS09Dgr H225H330H300H311H314H410 EUH071 Skin Corr. 1B;H314: C ≥ 0,1 %M = 100M = 1 D
616-035-00-5 cymoxanil (ISO);2-cyano-N-[(ethylamino)carbonyl]-2-(methoxyimino)acetamide 261-043-0 57966-95-7 Repr. 2Acute Tox. 4STOT RE 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H361fdH302H373 (blood, thymus)H317H400H410 GHS08GHS07GHS09Wng H361fdH302H373 (blood, thymus)H317H410  M = 1M = 1 '
((c)) the following entries are inserted in accordance with the order of the entries set out in Table 3.1:
'
050-028-00-2 2-ethylhexyl 10-ethyl-4,4-dimethyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate 260-829-0 57583-35-4 Repr. 2Acute Tox. 4STOT RE 1Skin Sens. 1A H361dH302H372 (nervous system, immune system)H317 GHS08GHS07Dgr H361dH302H372 (nervous system, immune system)H317   
050-029-00-8 dimethyltin dichloride 212-039-2 753-73-1 Repr. 2Acute Tox. 2Acute Tox. 3Acute Tox. 3STOT RE 1Skin Corr. 1B H361dH330H301H311H372 (nervous system, immune system)H314 GHS08GHS06GHS05Dgr H361dH330H301H311H372 (nervous system, immune system)H314 EUH071  
601-088-00-9 4-vinylcyclohexene 202-848-9 100-40-3 Carc. 2 H351 GHS08Wng H351   
601-089-00-4 muscalure; cis-tricos-9-ene 248-505-7 27519-02-4 Skin Sens. 1B H317 GHS07Wng H317   
604-090-00-8 4-tert-butylphenol 202-679-0 98-54-4 Repr. 2Skin Irrit. 2Eye Dam. 1 H361fH315H318 GHS08GHS05Dgr H361fH315H318   
604-091-00-3 etofenprox (ISO); 2-(4-ethoxyphenyl)-2-methylpropyl 3-phenoxybenzyl ether 407-980-2 80844-07-1 Lact.Aquatic Acute 1Aquatic Chronic 1 H362H400H410 GHS09Wng H362H410  M = 100M = 1 000 
606-146-00-7 tralkoxydim (ISO); 2-(N-ethoxypropanimidoyl)-3-hydroxy-5-mesitylcyclohex-2-en-1-one - 87820-88-0 Carc. 2Acute Tox. 4Aquatic Chronic 2 H351H302H411 GHS08GHS07GHS09Wng H351H302H411   
606-147-00-2 cycloxydim (ISO); 2-(N-ethoxybutanimidoyl)-3-hydroxy-5-(tetrahydro-2H-thiopyran-3-yl)cyclohex-2-en-1-one 405-230-9 101205-02-1 Repr. 2 H361d GHS08Wng H361d   
607-705-00-8 benzoic acid 200-618-2 65-85-0 STOT RE 1Skin Irrit. 2Eye Dam. 1 H372 (lungs) (inhalation)H315H318 GHS08GHS05Dgr H372 (lungs) (inhalation)H315H318   
607-706-00-3 methyl 2,5-dichlorobenzoate 220-815-7 2905-69-3 Acute Tox. 4STOT SE 3Aquatic Chronic 2 H302H336H411 GHS07GHS09Wng H302H336H411   
612-287-00-5 fluazinam (ISO); 3-chloro-N-[3-chloro-2,6-dinitro-4-(trifluoromethyl)phenyl]-5-(trifluoromethyl)pyridin-2-amine - 79622-59-6 Repr. 2Acute Tox. 4Eye Dam. 1Skin Sens. 1AAquatic Acute 1Aquatic Chronic 1 H361dH332H318H317H400H410 GHS08GHS07GHS05GHS09Dgr H361dH332H318H317H410  M = 10M = 10 
613-317-00-X penconazole (ISO); 1-[2-(2,4-dichlorophenyl)pentyl]-1H-1,2,4-triazole 266-275-6 66246-88-6 Repr. 2Acute Tox. 4Aquatic Acute 1Aquatic Chronic 1 H361dH302H400H410 GHS08GHS07GHS09Wng H361dH302H410  M = 1M = 1 
613-318-00-5 fenpyrazamine (ISO); S-allyl 5-amino-2-isopropyl-4-(2-methylphenyl)-3-oxo-2,3-dihydro-1H-pyrazole-1-carbothioate - 473798-59-3 Aquatic Chronic 2 H411 GHS09 H411   
616-212-00-7 3-iodo-2-propynyl butylcarbamate; 3-iodoprop-2-yn-1-yl butylcarbamate 259-627-5 55406-53-6 Acute Tox. 3Acute Tox. 4STOT RE 1Eye Dam. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H331H302H372 (larynx)H318H317H400H410 GHS06GHS08GHS05GHS09Dgr H331H302H372 (larynx)H318H317H410  M = 10M = 1 '
((2)) Table 3.2 is amended as follows:

((a)) the entry corresponding to index number 015-188-00-X is deleted;
((b)) the entries corresponding to index numbers 006-086-00-6, 015-154-00-4, 015-192-00-1, 601-023-00-4, 601-026-00-0, 603-061-00-7, 605-001-00-5 and 616-035-00-5 are replaced by the following corresponding entries:
'
006-086-00-6 fenoxycarb (ISO);ethyl [2-(4-phenoxyphenoxy)ethyl]carbamate 276-696-7 72490-01-8 Carc. Cat. 3; R40N; R50-53 Xn; NR: 40-50/53S: (2-)22-36/37-60-61 N; R50-53: C ≥ 25 %N; R51-53: 2,5 % ≤ C < 25 %R52-53: 0,25 % ≤ C < 2,5 % 
015-154-00-4 ethephon; 2-chloroethylphosphonic acid 240-718-3 16672-87-0 C; R34Xn; R20/21/22N; R51-53 C; NR: 20/21/22-34-51/53S: (1/2-)26-36/37/39-45-61 Xi; R37: 5 % ≤ C < 10 % 
015-192-00-1 tetrakis(2,6-dimethylphenyl)-m-phenylene biphosphate 432-770-2 139189-30-3 R43 XiR: 43S: (2-)24-37  
601-023-00-4 ethylbenzene 202-849-4 100-41-4 F; R11Xn; R20-48/20-65 F; XnR: 11-20-48/20-65S: (2-)16-24/25-29-62  
601-026-00-0 styrene 202-851-5 100-42-5 Repr. Cat. 3; R63Xn; R20-48/20Xi; R36/38R10 XnR: 10-20-36/38-48/20-63S: (2-)23-36/37-46 Xn; R20: C ≥ 12,5 %Xi; R36/38: C ≥ 12,5 % D
603-061-00-7 tetrahydro-2-furylmethanol;tetrahydrofurfuryl alcohol 202-625-6 97-99-4 Repr. Cat. 2; R61Repr. Cat. 3; R62Xi; R36 TR: 36-61-62S: 45-53 Xi; R36: C ≥ 10 % 
605-001-00-5 formaldehyde …% 200-001-8 50-00-0 Carc. Cat. 2; R45Muta. Cat. 3; R68T; R23/24/25C; R34R43 TR: 23/24/25-34-43-45-68S: 45-53 T; R23/24/25: C ≥ 25 %Xn; R20/21/22: 5 % ≤ C < 25 %C; R34: C ≥ 25 %Xi; R36/37/38: 5 % ≤ C < 25 %R43: C ≥ 0,2 % B, D
616-035-00-5 cymoxanil (ISO);2-cyano-N-[(ethylamino)carbonyl]-2-(methoxyimino)acetamide 261-043-0 57966-95-7 Repr. Cat. 3; R62-63Xn; R22-48/22R43N; R50-53 Xn; NR: 22-43-48/22-62-63-50/53S: (2-)36/37-46-60-61 N; R50-53: C ≥ 25 %N; R51-53: 2,5 % ≤ C < 25 %R52-53: 0,25 % ≤ C < 2,5 % '
((c)) the following entries are inserted in accordance with the order of the entries set out in Table 3.2:
'
050-028-00-2 2-ethylhexyl 10-ethyl-4,4-dimethyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate 260-829-0 57583-35-4 Repr. Cat. 3; R63T; R48/25Xn; R22R43 TR: 22-43-48/25-63S: (1/2-)36/37-45  
050-029-00-8 dimethyltin dichloride 212-039-2 753-73-1 Repr. Cat. 3; R63T+; R26T; R24/25-48/25C; R34 T+R: 24/25-26-34-48/25-63S: (1/2-)26-28-36/37/39-45-63  
601-088-00-9 4-vinylcyclohexene 202-848-9 100-40-3 Carc. Cat. 3; R40 XnR: 40S: (2-)36/37  
601-089-00-4 muscalure; cis-tricos-9-ene 248-505-7 27519-02-4 R43 XiR: 43S: (2-)24-37  
604-090-00-8 4-tert-butylphenol 202-679-0 98-54-4 Repr. Cat. 3; R62Xi; R38-41 XnR: 38-41-62S: (2-)26-36/37/39-46  
604-091-00-3 etofenprox (ISO); 2-(4-ethoxyphenyl)-2-methylpropyl 3-phenoxybenzyl ether 407-980-2 80844-07-1 R64N; R50-53 NR: 50/53-64S: 60-61 N; R50-53: C ≥ 0,25 %N; R51-53: 0,025 % ≤ C < 0,25 %R52-53: 0,0025 % ≤ C < 0,025 % 
606-146-00-7 tralkoxydim (ISO); 2-(N-ethoxypropanimidoyl)-3-hydroxy-5-mesitylcyclohex-2-en-1-one – 87820-88-0 Carc. Cat. 3; R40Xn; R22N; R51-53 Xn; NR: 22-40-51/53S: (2-)36/37-60-61  
606-147-00-2 cycloxydim (ISO); 2-(N-ethoxybutanimidoyl)-3-hydroxy-5-(tetrahydro-2H-thiopyran-3-yl)cyclohex-2-en-1-one 405-230-9 101205-02-1 F; R11Repr. Cat. 3; R63 F; XnR: 11-63S: (2-)16-36/37-46  
607-705-00-8 benzoic acid 200-618-2 65-85-0 T; R48/23Xi; R38-41 TR: 38-41-48/23S: (1/2-)26-39-45-63  
607-706-00-3 methyl 2,5-dichlorobenzoate 220-815-7 2905-69-3 Xn; R22N; R51-53 Xn; NR: 22-51/53S: (2-) 46-61  
612-287-00-5 fluazinam (ISO); 3-chloro-N-[3-chloro-2,6-dinitro-4-(trifluoromethyl)phenyl]-5-(trifluoromethyl)pyridin-2-amine - 79622-59-6 Repr. Cat. 3; R63Xn; R20Xi; R41R43N; R50-53 Xn; NR: 20-41-43-50/53-63S: (2-)26-36/37/39-46-60-61 N; R50-53: C ≥ 2,5 %N; R51-53: 0,25 % ≤ C < 2,5 %R52-53: 0,025 % ≤ C < 0,25 % 
613-317-00-X penconazole (ISO); 1-[2-(2,4-dichlorophenyl)pentyl]-1H-1,2,4-triazole 266-275-6 66246-88-6 Repr. Cat. 3; R63Xn; R22N; R50-53 Xn; NR: 22-50/53-63S: (2-) 36/37-46-60-61 N; R50-53: C ≥ 25 %N; R51-53: 2,5 % ≤ C < 25 %R52-53: 0,25 % ≤ C < 2,5 % 
613-318-00-5 fenpyrazamine (ISO); S-allyl 5-amino-2-isopropyl-4-(2-methylphenyl)-3-oxo-2,3-dihydro-1H-pyrazole-1-carbothioate - 473798-59-3 N; R51-53 NR: 51/53S: 60-61  
616-212-00-7 3-iodo-2-propynyl butylcarbamate; 3-iodoprop-2-yn-1-yl butylcarbamate 259-627-5 55406-53-6 T; R23-48/23Xn; R22Xi; R41R43N; R50 T; NR: 22-23-41-43-48/23-50S: (1/2-)24-26-37/39-45-63 N; R50: C ≥ 2,5 % '
